To bridge this gap of knowledge, the present systematic review was conducted with an aim to assess the time on treatment (drug survival and reasons for discontinuation) with TNF inhibitors, from published European registry studies among patients with RA. This evidence concerns the gene TNF and rheumatoid arthritis.